Clinical Trials on Postmenopausal Breast Cancer

Total 54512 results

Centre Francois Baclesse
National Cancer Institute, France; ARC Foundation for Cancer Research

Terminated

A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors (OLYMPE)

Metastatic Breast Cancer | Postmenopausal

France
Yonsei University

Recruiting

Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients

Metastatic Breast Cancer | HER2-positive Breast Cancer | Postmenopausal

Korea, Republic of
Novartis Pharmaceuticals

Completed

Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Postmenopausal Women | Locally Advanced Metastatic Breast Cancer

Israel
Janssen Research & Development, LLC

Completed

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Postmenopausal | Metastatic ER+ Her2- Breast Cancer

United States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
AstraZeneca

Completed

LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer (LINE)

Local Advanced or Metastatic Postmenopausal Breast Cancer

Russian Federation
AstraZeneca

Completed

Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer. (D6090C00002)

Postmenopausal Women With ER+ HER2- Primary Breast Cancer

Germany, United Kingdom
Novartis Pharmaceuticals

Completed

Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy (Treat ER+ight)

HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer

Canada
Washington University School of Medicine

Completed

Effect of Aromatase Inhibitors on Bones and Genes

Breast Cancer | Postmenopausal

United States
Lund University Hospital

Completed

Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer

Breast Cancer | Postmenopausal

Sweden
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.

Postmenopause | Postmenopausal Osteoporosis
Nycomed

Completed

PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)

Osteoporosis | Postmenopause

Germany
University of Michigan Rogel Cancer Center
Susan G. Komen Breast Cancer Foundation

Completed

A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer

Breast Cancer | Postmenopausal Bone Loss

United States
Universidade Federal do Triangulo Mineiro

Unknown

Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors.

Postmenopause | Breast Cancer Survivors

Brazil
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors

Cancer Survivor | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor-positive Breast Cancer | Postmenopausal

United States
Novartis Pharmaceuticals
University of Sheffield; Danish Breast Cancer Cooperative Group

Completed

A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women

Denmark, United Kingdom
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer

Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Postmenopausal | Estrogen Receptor Status

United States
Universidad de La Frontera

Completed

Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer (MUSCLE-CLIM)

Resistance Training | Postmenopause | Breast Cancer Survivors

Chile
German Cancer Research Center

Completed

Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer Prognosis

Inflammation | Breast Cancer | Lifestyle | Hormone Therapy | Breast Cancer Mortality | Inflammatory Biomarkers | Breast Cancer Survival | Postmenopausal Breast Cancer | Genetic Factors | Phytoestrogens
University of Arkansas
AMAG Pharmaceuticals, Inc.

Terminated

Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors

Vaginal Atrophy | Breast Cancer Female | Postmenopausal Symptoms | Long-term Survivors

United States
AstraZeneca

Completed

A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer (ACT-FASTER:)

Breast Cancer | Postmenopause

Germany
University of Michigan Rogel Cancer Center
Breast Cancer Research Foundation

Recruiting

Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer

Breast Cancer | Postmenopausal

United States
Universidade Estadual Paulista Júlio de Mesquita...

Completed

Combined Training on Body Composition of Postmenopausal Women Undergoing Treatment for Breast Cancer

Breast Cancer | Aromatase Inhibitors | Postmenopausal
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; United... and other collaborators

Completed

Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy

Breast Cancer | Menopause | Postmenopausal Bone Loss

United States
University Hospital, Ghent

Completed

Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes

Breast Cancer | Hot Flashes | Postmenopausal Symptoms

Belgium
Baylor University
University of Michigan; National Center for Complementary and Integrative Health...

Completed

A Mind-Body Intervention for Hot Flash Management

Breast Cancer | Hot Flashes | Postmenopausal Symptoms

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Positive | Progesterone Receptor Positive | Postmenopausal | KIT Positive | PDGFR Positive

United States
Universidad de La Frontera

Not yet recruiting

Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy (PRE-RET)

Breast Cancer | Resistance Training | Postmenopause | Prehabilitation

Chile
Institut fuer Frauengesundheit
Novartis; ClinSol

Unknown

Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace) (PreFace)

is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.

Germany
Vejle Hospital

Completed

Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture

Breast Cancer | Postmenopause

Denmark
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Stage 0 Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | HER2/Neu Negative | Postmenopausal

United States
Jonsson Comprehensive Cancer Center
Bayer; Translational Research in Oncology-U.S. Inc. (TRIO-US)

Terminated

Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer

Stage I Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative and other conditions

United States
Johns Hopkins University

Completed

Auricular Point Acupressure to Self-Manage Chronic Pain or Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors: Effectiveness and Scientific Underpinnings

Aromatase Inhibitor | Musculoskeletal Symptoms | Postmenopausal Breast Cancer Survivors

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer

Stage I Breast Cancer | Cancer Survivor | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Stage... and other conditions

United States
University of Vermont
University of Vermont Medical Center

Completed

Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors (VCC0910)

Breast Cancer | Overweight | Postmenopausal

United States
Novartis

Completed

Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

Osteoporosis | Postmenopausal

Germany
Olivia Cardenas-Trowers, M.D.
AMAG Pharmaceuticals, Inc.

Withdrawn

Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women

Menopause | Postmenopause | Recurrent Urinary Tract Infection | Postmenopausal Symptoms | Postmenopausal Syndrome

United States
National Center for Complementary and Integrative...

Completed

Effects of Black Cohosh on Menopausal Hot Flashes

Hot Flashes | Osteoporosis, Postmenopausal | Postmenopause

United States
University of Sao Paulo General Hospital
Instituto Brasileiro de Controle do Cancer

Unknown

Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation

Breast Neoplasms | Postmenopausal Disorder

Brazil
University of Arizona
National Cancer Institute (NCI)

Completed

Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer Survivors

Overweight | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer... and other conditions

United States
Jonsson Comprehensive Cancer Center

Recruiting

Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors

Arthralgia | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer... and other conditions

United States
Prof. W. Janni

Active, not recruiting

DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).

HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer | HER2-negative Circulating Tumor Cells | Postmenopausal Female Patients

Germany
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Completed

Broccoli Sprout Extract in Treating Patients With Breast Cancer

Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | Lobular Breast Carcinoma | Postmenopausal | Ductal Breast Carcinoma | Ductal Breast Carcinoma In Situ

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

Advanced Malignant Solid Neoplasm | Recurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7 | Postmenopausal | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 and other conditions

United States
Northwestern University
National Cancer Institute (NCI)

Not yet recruiting

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Estrogen-receptor-positive Breast Cancer | HER2/Neu-Negative Breast Cancer | Advanced Breast Cancerv

United States
Fundació Eurecat

Completed

Metabotyping in the Postmenopausal Stage (SHE-HEALTH)

Menopause | Postmenopausal Symptoms | Postmenopausal Disorder

Spain
OHSU Knight Cancer Institute
Susan G. Komen Breast Cancer Foundation

Completed

Strength Training for Older Breast Cancer Survivors

Breast Neoplasm | Osteoporosis, Postmenopausal

United States
Hospital Regional 1o de Octubre
Universidad Nacional Autonoma de Mexico; National Polytechnic Institute, Mexico

Completed

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment

Hyperparathyroidism, Primary | Hyperparathyroidism, Secondary | Hypovitaminosis D | Postmenopause | Postmenopausal Osteoporosis

Mexico

Clinical Trials on Postmenopausal Breast Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations